Medicinal inorganic chemistry – challenges, opportunities and guidelines to develop the next generation of radioactive, photoactivated and active site inhibiting metal-based medicines-Reference-Cited by-同舟云学术

Medicinal inorganic chemistry – challenges, opportunities and guidelines to develop the next generation of radioactive, photoactivated and active site inhibiting metal-based medicines

Published:2022 Issue:18 Volume:51 Page:7715-7731
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Lengacher Raphael¹,Marlin Axia¹,Śmiłowicz Dariusz¹,Boros Eszter¹^ORCID

Affiliation:

1. Department of Chemistry, Stony Brook University, Stony Brook, 11790 New York, USA

Abstract

Medicinal inorganic chemistry is a burgeoning subfield of medicinal chemistry that focuses on the development of metal-based diagnostic and therapeutic agents.

Funder

National Institute of General Medical Sciences

Gordon and Betty Moore Foundation

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/CS/D2CS00407K

Reference49 articles.

1. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy